株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の創傷用生物製剤市場:2016〜2020年

Global Wound Biologics Market 2016-2020

発行 TechNavio (Infiniti Research Ltd.) 商品コード 351694
出版日 ページ情報 英文 54 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
世界の創傷用生物製剤市場:2016〜2020年 Global Wound Biologics Market 2016-2020
出版日: 2016年02月03日 ページ情報: 英文 54 Pages
概要

生物製剤による創傷治療プロセスは、抗菌、抗酸化、抗炎症特性をもつ植物由来の活性生分子などの生物学的薬剤を応用して本来の修復メカニズムを再構築するものです。世界の創傷用生物製剤市場は、2016〜2020年にかけCAGR20.63%で拡大すると予測されています。

当レポートでは、世界の創傷用生物製剤市場について調査し、創傷用生物製剤の概要、市場の動向と2020年までの予測、市場の課題、主要ベンダーの動向と主要ベンダーが直面する市場の機会と脅威などをまとめています。

第1章 エグゼクティブサマリー

第2章 当レポートの範囲

第3章 市場調査方法

第4章 イントロダクション

第5章 市況

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第6章 製品別市場セグメンテーション

  • 皮膚代用別
  • 増殖因子別

第7章 地域別セグメンテーション

  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋地域

第8章 市場促進因子

第9章 促進因子の影響

第10章 市場の課題

  • 限定された臨床データの入手性
  • 代替物の入手性
  • 厳しい法規制認可プロセス

第11章 促進因子と課題の影響

第12章 市場動向

  • 技術の進歩
  • パイプライン製品の増加
  • 併用被覆剤の需要
  • 新規治療法の登場

第13章 ベンダー環境

  • 競合シナリオ
  • 主なニュース
  • 合併・買収
  • 市場シェア分析:2015年
  • Smith & Nephew
  • Organogenesis
  • Acelity
  • Integra LifeSciences
  • その他の注目すべきベンダー

第14章 付録

第15章 Technavioについて

図表

目次
Product Code: IRTNTR8401

About Wound Biologics

Mechanical, chemical, thermal, and radiogenic damages can cause cuts, tears, and punctures in the skin, blood vessels, nerves, muscles, internal organs, bones, and joints. Wounds are of two types: acute and chronic. The reparative process in acute wounds occurs at a predictable and expected rate leading to faster healing, while it fails to occur in a predictable amount of time in chronic wounds.

Biologic wound healing process helps re-establish the innate repair mechanisms and may involve the application of biological agents such as plant-derived active biomolecules having antimicrobial, antioxidant, and anti-inflammatory attributes. Biologic dressings prevent evaporative water loss, protein and electrolyte loss, heat loss, and wound contamination. Wound biologics such as granular wound beds permit autolytic debridement for the healing process.

Technavio's analysts forecast the global wound biologics market to grow at a CAGR of 20.63% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global wound biologics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of:

  • Skin substitutes
  • Growth factors

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Wound Biologics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Acelity
  • Integra LifeSciences
  • Organogenesis
  • Smith & Nephew

Other Prominent Vendors

  • Avita Medical
  • BioDlogics
  • ConvaTec
  • Cytori Therapeutics
  • Intercytex
  • MacroCure
  • Molyncke Health Care
  • Nuo Therapeutics
  • Osiris Therapeutics
  • Regenerys

Market driver

  • Prevalence of chronic diseases
  • For a full, detailed list, view our report

Market challenge

  • Limited availability of clinical data
  • For a full, detailed list, view our report

Market trend

  • Advances in technology
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Global wound biologics market by skin substitutes
  • Global wound biologics market by growth factors

PART 07: Geographical segmentation

  • Wound biologics market in Americas
  • Wound biologics market in EMEA
  • Wound biologics market in APAC

PART 08: Market drivers

  • Prevalence of chronic diseases
  • Availability of different skin substitutes
  • Rise in geriatric population

PART 09: Impact of drivers

PART 10: Market challenges

  • Limited availability of clinical data
  • Availability of alternatives
  • Stringent regulatory approval process

PART 11: Impact of drivers and challenges

PART 12: Market trends

  • Advances in technology
  • Increase in pipeline products
  • Demand for combination dressings
  • Emergence of new treatment options

PART 13: Vendor landscape

  • Competitive scenario
  • Key news
  • Mergers and acquisitions
  • Market share analysis 2015
  • Smith & Nephew
  • Organogenesis
  • Acelity
  • Integra LifeSciences
  • Other prominent vendors

PART 14: Appendix

  • List of abbreviations

PART 15: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Stages of wound healing
  • Exhibit 03: Types of wounds
  • Exhibit 04: Global wound biologics market 2015-2020 ($ billions)
  • Exhibit 05: Five forces analysis
  • Exhibit 06: Global wound biologics market segmentation by product
  • Exhibit 07: Global wound biologics market by skin substitutes 2015-2020 ($ millions)
  • Exhibit 08: Growth factors involved in wound healing
  • Exhibit 09: Global wound biologics market by growth factors 2015-2020 ($ millions)
  • Exhibit 10: Global wound biologics market segmentation by geography 2015
  • Exhibit 11: Wound biologics market in Americas 2015-2020 ($ millions)
  • Exhibit 12: Wound biologics market in EMEA 2015-2020 ($ millions)
  • Exhibit 13: Wound biologics market in APAC 2015-2020 ($ millions)
  • Exhibit 14: Global wound biologics market segmentation by geography 2015-2020 ($ millions)
  • Exhibit 15: Global wound biologics market segmentation by geography 2015-2020
  • Exhibit 16: Different commercially available skin substitutes
  • Exhibit 17: Impact of drivers
  • Exhibit 18: Impact of drivers and challenges
  • Exhibit 19: Middle- and late-stage wound biologics in pipeline
  • Exhibit 20: Ranking of vendors 2015
  • Exhibit 21: Market share of vendors 2015
  • Exhibit 22: Smith & Nephew: Business segmentation by revenue 2014
  • Exhibit 23: Smith & Nephew: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 24: Smith & Nephew: Key takeaways
  • Exhibit 25: Organogenesis: Key takeaways
  • Exhibit 26: Acelity: Business segmentation by revenue 2014
  • Exhibit 27: Acelity: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 28: Acelity: Key takeaways
  • Exhibit 29: Integra LifeSciences: Key takeaways
Back to Top